SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea · Delayed Price · Currency is KRW 1,620.00
-20.00 (-1.22%)
At close: Jul 25, 2025, 3:30 PM KST
SAMSUNG PHARM. Co., LTD. Market Cap
SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 152.47 billion as of July 25, 2025. Its market cap has increased by 5.74% in one year.
Market Cap
152.47B
Enterprise Value
n/a
Revenue
44.29B
Ranking
n/a
PE Ratio
12.00
Stock Price
1,620.00
Market Cap Chart
Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 152.47B, an increase of 752.54%. That is a compound annual growth rate of 7.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 152.47B | 5.33% |
| Dec 30, 2024 | 144.76B | -0.84% |
| Dec 28, 2023 | 145.99B | -18.99% |
| Dec 29, 2022 | 180.22B | -45.48% |
| Dec 30, 2021 | 330.57B | -11.17% |
| Dec 30, 2020 | 372.12B | 50.47% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.44T |
| Celltrion | 39.84T |
| ALTEOGEN | 25.49T |
| Yuhan | 9,219.06B |
| SK Biopharmaceuticals | 7,987.95B |
| Peptron | 6,628.10B |
| HLB Co., Ltd. | 6,499.61B |
| PharmaResearch | 6,015.61B |